| Issue Date | Title | Author(s) |
| Oct-2024 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | Bryazka, D; Reitsma, MB; Abate, YH; Abd Al Magied, AHA; Abdelkader, A, et al |
| 18-May-2024 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | Brauer, M; Roth, GA; Aravkin, AY; Zheng, P; Abate, KH, et al |
| 18-May-2024 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | Naghavi, M; Ong, KL; Aali, A; Ababneh, HS; Abate, YH, et al |
| Aug-2024 | Global estimates on the number of people blind or visually impaired by glaucoma: a meta-analysis from 2000 to 2020 | Bourne, RRA; Jonas, JB; Friedman, D; Nangia, V; Bron, A, et al |
| Aug-2024 | Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020 | Little, J-A; Congdon, NG; Resnikoff, S; Braithwaite, T; Leasher, J, et al |
| 18-May-2024 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | Ferrari, AJ; Santomauro, DF; Aali, A; Abate, YH; Abbafati, C, et al |
| 17-Dec-2022 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 | Ikuta, KS; Swetschinski, LR; Aguilar, GR; Sharara, F; Mestrovic, T, et al |
| 1-Oct-2023 | Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 | Black, RJ; Cross, M; Haile, LM; Culbreth, GT; Steinmetz, JD, et al |
| Oct-2024 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | Feigin, VL; Abate, MD; Abate, YH; Abd ElHafeez, S; Abd-Allah, F, et al |
| 1-Oct-2023 | Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 | Wu, D; Jin, Y; Xing, Y; Abate, MD; Abbasian, M, et al |
| Aug-2023 | Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 | Thomson, AM; McHugh, TA; Oron, AP; Teply, C; Lonberg, N, et al |
| Sep-2023 | Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021 | Gardner, WM; Razo, C; McHugh, TA; Hagins, H; Vilchis-Tella, VM, et al |